WallStSmart
DHI

DR Horton Inc

NYSE: DHI · CONSUMER CYCLICAL · RESIDENTIAL CONSTRUCTION

$151.65
-3.04% today

Updated 2026-04-29

Market cap
$43.00B
P/E ratio
14.24
P/S ratio
1.29x
EPS (TTM)
$10.65
Dividend yield
1.09%
52W range
$113 – $183
Volume
2.7M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

DR Horton Inc (DHI) Financial Forecast & Price Target 2030

Research-backed projections from analyst consensus, management guidance, and sector analysis.

Price target summary

Current
$151.65
Consensus
$157.92
+4.13%
2030 Target
$1,774.06
+1069.84%
DCF
$124.51
-31.60% MoS
24 analysts:
3 Buy8 Hold4 Sell

Management guidance

No specific CEO revenue targets found in provided data. Latest analyst consensus (Jan 2026) projects FY2026 revenue of $34.4B (+0.44% YoY) and FY2027 revenue of $36.43B (+5.89% YoY). Management has expanded credit facilities to $4.0B through 2031, indicating confidence in capital deployment and growth initiatives.

Sources: Management guidance, analyst consensus, sector analysishigh confidence

Revenue & price projection

Actual revenue Projected revenue Base case Bull to bear range
Bull case (2030)
$2,961.43
$43.2B Rev × 20x P/S
Base case (2030)
$1,774.06
$43.2B Rev × 12x P/S
Bear case (2030)
$1,187.37
$43.2B Rev × 8x P/S

Financial forecast — research-backed

Metric2023202420252026 (E)2027 (E)2028 (E)2029 (E)2030 (E)
Revenue$35.5B$36.8B$34.3B$34.4B$36.4B$38.5B$40.8B$43.2B
Revenue growth—3.8%-6.9%0.4%5.9%5.7%5.9%5.9%
EPS$13.84$14.36$2.03$10.79$12.63$14.20$15.80$16.90
P/S ratio———12.0x12.0x12.0x12.0x12.0x
Implied price———$1,424.84$1,508.65$1,592.47$1,676.28$1,774.06

Catalysts & risks

Growth catalysts
+ Interest rate normalization driving mortgage affordability improvements and demand acceleration
+ Expansion of credit facilities ($4.0B) enabling aggressive land acquisition and project development
+ New community launches in high-growth markets (Georgia, Charlotte) capturing coastal/suburban migration
+ Potential Trump administration housing policies and 'Trump homes' initiatives benefiting large builders
+ Supply chain stabilization and cost normalization improving margins from current 9.9% levels
Key risks
- Mortgage rates remaining elevated, constraining buyer affordability and demand elasticity
- Product quality issues (PEX pipe defects in Georgia homes) creating warranty liabilities and reputational damage
- Cyclical downturn risk given consumer weakness signals in Q4 2025 (-6.93% YoY revenue decline)
- Potential antitrust probe into homebuilder practices reducing industry consolidation benefits
- Supply chain disruptions and labor cost inflation pressuring margins despite revenue growth

Methodology

DR Horton Inc's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 24 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.

WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 7, 2026.